Incyte INCY
NASDAQ INCY
$127.71 -0.29 (-0.23%)
As of: Sep 4, 2026 · 2:31 PM EDT

Incyte (INCY) Free Cash Flow (2010 - 2026)

Incyte's (INCY) quarterly Free Cash Flow came in at $495.2 million in Q2 2026, up 1829.52% YoY from $25.7 million in Q2 2025, and up 37.89% on a QoQ basis from $359.2 million in Q1 2026.

Analysis

Incyte (INCY) Free Cash Flow (2010 - 2026) Analysis & Trends

Incyte (INCY) has 17 years of Free Cash Flow data on file, last reported at $495.2 million in Q2 2026.

  • Quarterly Free Cash Flow rose 1829.52% year-over-year to $495.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.9 billion (up 100.45% YoY) and the FY2025 annual result came in at $1.4 billion, up 443.87% from the prior year.
  • Free Cash Flow grew to $495.2 million in Q2 2026, from $359.2 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $544.6 million in Q3 2025 to a low of -$629.7 million in Q2 2024.
  • A 5-year average of $211.9 million and a median of $262.6 million in 2022 frame the typical range for Free Cash Flow.
  • Annual changes were most pronounced in 2024 — Free Cash Flow sank 310.47% — and 2026, when it surged 1829.52%.
  • Tracing INCY's Free Cash Flow over 5 years: stood at $262.4 million in 2022, then slumped by 44.56% to $145.5 million in 2023, then soared by 150.12% to $363.8 million in 2024, then surged by 43.31% to $521.4 million in 2025, then retreated by 5.02% to $495.2 million in 2026.
  • The last three Free Cash Flow figures came in at $495.2 million (Q2 2026), $359.2 million (Q1 2026), and $521.4 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Vertex Pharmaceuticals 138.77 Bn 130.92 Bn 2.84 Bn 1.01 Bn
2 Regeneron Pharmaceuticals 85.51 Bn 77.52 Bn 3.93 Bn 572.80 Mn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn -
4 Moderna 58.20 Bn 53.06 Bn 52.00 Mn -563.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn - -389.61 Mn
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn 437.80 Mn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn 292.04 Mn
8 Royalty Pharma 28.40 Bn 27.56 Bn - 477.44 Mn
9 Insmed 27.44 Bn 26.28 Bn 358.27 Mn -95.09 Mn
10 Incyte 25.59 Bn 21.05 Bn 1.57 Bn 495.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 495.25 Mn
Mar 31, 2026 359.15 Mn
Dec 31, 2025 521.42 Mn
Sep 30, 2025 544.64 Mn
Jun 30, 2025 25.67 Mn
Mar 31, 2025 262.90 Mn
Dec 31, 2024 363.83 Mn
Sep 30, 2024 305.68 Mn
Jun 30, 2024 -629.71 Mn
Mar 31, 2024 209.26 Mn
Dec 31, 2023 145.46 Mn
Sep 30, 2023 136.86 Mn
Jun 30, 2023 299.19 Mn
Mar 31, 2023 -117.51 Mn
Dec 31, 2022 262.39 Mn
Sep 30, 2022 268.57 Mn
Jun 30, 2022 162.41 Mn
Mar 31, 2022 198.74 Mn
Dec 31, 2021 80.89 Mn
Sep 30, 2021 222.95 Mn